Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Talbot

Showing results (451-460 of 576) with videos related to

Pageof 58
Sort By:
Cancer Chemotherapy and Pharmacology|July 27, 2000
Evaluation of toremifene for reversal of multidrug resistance in renal cell cancer patients treated with vinblastineJ P Braybrooke, K A Vallis, S Houlbrook, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 24, 2010
Association of long-term administration of the survivin mRNA-targeted antisense oligonucleotide LY2181308 with reversible kidney injury in a patient with metastatic melanomaWilliam G Herrington, Denis C Talbot, Michael M Lahn, et al.
Bone Marrow Transplantation|July 1, 1990
Cyclosporine-induced graft-versus-host disease following autologous bone marrow transplantation in acute myeloid leukaemiaD C Talbot, R L Powles, J P Sloane, et al.
Gut|July 1, 1992
Double blind, controlled trial of 4-aminosalicylic acid and prednisolone enemas in distal ulcerative colitisL J O'Donnell, A S Arvind, P Hoang, et al.
British Journal of Cancer|November 21, 1998
A phase II study of bryostatin 1 in metastatic malignant melanomaD J Propper, V Macaulay, K J O'Byrne, et al.
Virchows Archiv : an International Journal of Pathology|April 17, 2002
Beta-catenin expression and allelic loss at APC in sporadic colorectal carcinogenesisXingpei Hao, Ian M Frayling, Teresa C Willcocks, et al.
Anticancer Research|March 12, 1998
A phase II study evaluating the effect of tamoxifen on DNA repair in melanoma patients treated with dacarbazineM P Saunders, A J Salisbury, K J O'Byrne, et al.
British Journal of Cancer|May 1, 1996
Modulation of bryostatin 1 muscle toxicity by nifedipine: effects on muscle metabolism and oxygen supplyC H Thompson, V M Macaulay, K J O'Byrne, et al.
Journal of the National Cancer Institute|November 17, 1993
Phase I study of bryostatin 1: assessment of interleukin 6 and tumor necrosis factor alpha induction in vivo. The Cancer Research Campaign Phase I CommitteeP A Philip, D Rea, P Thavasu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2007
Phase II study of vinflunine in malignant pleural mesotheliomaDenis C Talbot, Jacques Margery, Gérard Dabouis, et al.
Pageof 58

Showing results (451-460 of 576) with videos related to

Sort By:
Pageof 58
Cancer Chemotherapy and Pharmacology|July 27, 2000
Evaluation of toremifene for reversal of multidrug resistance in renal cell cancer patients treated with vinblastineJ P Braybrooke, K A Vallis, S Houlbrook, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 24, 2010
Association of long-term administration of the survivin mRNA-targeted antisense oligonucleotide LY2181308 with reversible kidney injury in a patient with metastatic melanomaWilliam G Herrington, Denis C Talbot, Michael M Lahn, et al.
Bone Marrow Transplantation|July 1, 1990
Cyclosporine-induced graft-versus-host disease following autologous bone marrow transplantation in acute myeloid leukaemiaD C Talbot, R L Powles, J P Sloane, et al.
Gut|July 1, 1992
Double blind, controlled trial of 4-aminosalicylic acid and prednisolone enemas in distal ulcerative colitisL J O'Donnell, A S Arvind, P Hoang, et al.
British Journal of Cancer|November 21, 1998
A phase II study of bryostatin 1 in metastatic malignant melanomaD J Propper, V Macaulay, K J O'Byrne, et al.
Virchows Archiv : an International Journal of Pathology|April 17, 2002
Beta-catenin expression and allelic loss at APC in sporadic colorectal carcinogenesisXingpei Hao, Ian M Frayling, Teresa C Willcocks, et al.
Anticancer Research|March 12, 1998
A phase II study evaluating the effect of tamoxifen on DNA repair in melanoma patients treated with dacarbazineM P Saunders, A J Salisbury, K J O'Byrne, et al.
British Journal of Cancer|May 1, 1996
Modulation of bryostatin 1 muscle toxicity by nifedipine: effects on muscle metabolism and oxygen supplyC H Thompson, V M Macaulay, K J O'Byrne, et al.
Journal of the National Cancer Institute|November 17, 1993
Phase I study of bryostatin 1: assessment of interleukin 6 and tumor necrosis factor alpha induction in vivo. The Cancer Research Campaign Phase I CommitteeP A Philip, D Rea, P Thavasu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2007
Phase II study of vinflunine in malignant pleural mesotheliomaDenis C Talbot, Jacques Margery, Gérard Dabouis, et al.
Pageof 58